Themis Medicare Ltd

Themis Medicare Limited submitted to the Bombay Stock Exchange and National Stock Exchange a certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended September 30, 2026, as confirmed by MUFG Intime India Private Limited, formerly Link Intime India Private Limited, its Registrar and Share Transfer Agent.

Themis Medicare Ltd announced ratings actions from CARE Ratings Limited, resulting in downgrades across several instruments. Specifically, CARE Ratings Limited downgraded the Long Term Bank Facilities from CARE BBB-; Negative to CARE BB+; Stable, and Short Term Bank Facilities from CARE A3 to CARE A4+; Stable, impacting amounts of Rs 77.39 crore and Rs 48.50 crore respectively, alongside Corporate Bonds and Debentures; the agency also assigned a rating of CARE A3 to Non-fund-based - ST-BG/LC of Rs 48.50 crore on August 12, 2025, and a rating of CARE BBB-; Negative to Fund-based - LT-Cash Credit of Rs 37.85 crore on the same date, with previous ratings of CARE BBB-; Stable assigned on June 25, 2025, and CARE BBB- on November 22, 2024 (RWP); the downgrades reflect a deterioration in key financial metrics including a TD/GCA ratio moving from 2.29x in FY25 to 10.79x (FY26) and an interest coverage ratio declining from 5.04x in FY25 to 0.26x (FY26), while CareEdge Ratings and other agencies provided no rating data.

Themis Medicare Ltd announced ratings actions from multiple agencies concerning its various bank facilities and limits. CARE Ratings Limited downgraded the Long Term Bank Facilities amounting to Rs 77.39 crore from CARE BBB-; Negative to CARE BB+; Stable, and simultaneously downgraded the Short Term Bank Facilities amounting to Rs 48.50 crore from CARE A3 to CARE A4+, alongside downgrading the Long Term Bank Facilities again amounting to Rs 77.39 crore from CARE BBB-; Negative to CARE BB+; Stable; additionally, CARE Ratings assigned a BBB rating with a Stable outlook to long-term bank loan facilities aggregating to Rs 100 crore, and noted that surveillance/review will be undertaken periodically, while also indicating that ratings for certain bank facilities are currently under "ISSUER NOT COOPERATING" status; CareEdge Ratings indicated that ratings reflect opinions as on the date of the rating, and no rating data was found for any instruments from any other agency.

Themis Medicare Limited informed the BSE and NSE that its members approved a dividend of Rs 0.50 per equity share, totaling Rs 46,050,060, for the financial year ended March 31, 2026, and approved an amendment to the company’s Articles of Association, specifically modifying Article 13(1) Clause (c) to broaden the scope of permissible purchasers of company shares.

Themis Medicare Limited announced that its 56th Annual General Meeting was held on Wednesday, September 30, 2026, at its registered office in Vapi, Gujarat, with Dr. Dinesh S. Patel chairing the proceedings, and included the consideration and adoption of the Audited Standalone and Consolidated Financial Statements for the financial year ended March 31, 2026, the re-appointment of Mr. Rajneesh Anand as a director, and a dividend declaration, alongside special business items including the ratification of the Cost Auditor’s remuneration and an amendment to the Articles of Association.

Themis Medicare Limited informed the Bombay Stock Exchange and National Stock Exchange of India that it will close its trading window for company shares and securities starting Thursday, October 1, 2026, in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and will reopen after 48 hours from the declaration of unaudited financial results for the quarter and half year ending September 30, 2026, by the company’s board of directors.

Themis Medicare Limited has set September 23, 2026, as the record date for determining entitlement to a final dividend for the financial year ended March 31, 2026, subject to shareholder approval at the company’s 56th Annual General Meeting scheduled for September 30, 2026.

Themis Medicare Ltd share price declined by 4.73% to Rs 107.65. The Company's net profit saw a strong growth of 176.83% to Rs 24.61 crore, while revenue from operations gained 13.63% to Rs 86.96 crore in Q2FY26 over Q1FY26. The market capitalization of Pharmaceuticals industry group stocks on BSE stood at Rs 25.19 lakh crore, gaining 4.61%. It has marginally improved by 0.97% over last one week and heading higher by 11.17% in last one month while the market capitalization of Themis Medicare Ltd has softened by 4.44% and 9.91% in the same period respectively. Profit before tax (PBT) of Themis Medicare Ltd stood at Rs 38.6 crore in Q2 FY26, tanking 374.54% year-on-year, and jumping 326.05% quarter-on-quarter. EBITDA came in at Rs 53 crore, surging by 374.33% YoY and tumbling by 59444.44% sequentially. Total expenses witnessed a sharp rise of 88.30% to Rs 141.92 crore in Q2FY26 over Q2FY25. During the quarter, cost of materials consumed stood at Rs 17.63 crore, witnessing a sharp rise of 23.55% YoY, while employee benefits expense was at Rs 22.18 crore, inching up 5.32% YoY. For the TTM ended FY26, revenue from operations inched higher 6.22% to Rs 405.51 crore, while net profit plunged by 31.46% to Rs 29.83 crore, compared to previous TTM. EBITDA surged by 4343% to Rs 44.38 crore, and PBT collapsed by 25.77% to Rs 39.67 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 34.71 crore in FY26, as against Rs 22.09 crore in FY25. Themis Medicare Ltd gained 1.27% in last one year, outperforming the benchmark BSE Sensex which has slipped by 2.83% during the same period.

Themis Medicare Limited will hold a board meeting on Thursday, August 13, 2026, to approve the standalone and consolidated unaudited financial results for the quarter ended June 30, 2026, along with the statutory auditors’ limited review reports, according to a filing with the BSE Limited and National Stock Exchange of India Limited. The company had previously closed its trading window for designated persons from July 1, 2026, until 48 hours after the financial results are published, in compliance with SEBI regulations.

Vividhmargi Investments Private Limited has disclosed pledging 30,00,000 equity shares of Themis Medicare Limited on July 30, 2026, according to a filing with the BSE Limited and National Stock Exchange of India Limited. The pledge, representing 3.26% of the total share capital, was created against borrowing in favor of CTL Trusteeship Limited (Trustee) for Kotak Credit Opportunities Fund – Kotak Credit Opportunities Fund (Lender). Vividhmargi Investments Private Limited currently holds 2,44,29,460 shares, representing 26.52% of Themis Medicare Limited’s share capital.